BIT
CBST

BlackRock Institutional Trust’s CUBIST PHARMACEUTICALS INC CBST Stock Holding History

BlackRock Institutional Trust’s Portfolio CBST Stock Details CBST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-2,103,858
Closed -$212M – 3987
2014
Q4 		$212M Sell
2,103,858
-2,100
-0.1% -$163K 0.03% 520
2014
Q3 		$140M Sell
2,105,958
-17,460
-0.8% -$1.15M 0.02% 672
2014
Q2 		$148M Buy
2,123,418
+71,734
+3% +$4.88M 0.02% 679
2014
Q1 		$150M Buy
2,051,684
+72,349
+4% +$5.39M 0.03% 661
2013
Q4 		$136M Buy
1,979,335
+177,324
+10% +$11.5M 0.02% 672
2013
Q3 		$115M Buy
1,802,011
+184,507
+11% +$11.2M 0.02% 712
2013
Q2 		$78.1M Buy
+1,617,504
New +$79.5M 0.02% 877

BlackRock Institutional Trust's CBST Position: Q1 2015 in Review

BlackRock Institutional Trust sold out of CUBIST PHARMACEUTICALS INC (CBST) in Q1 2015, closing a stake of 2,103,858 shares — an estimated $212M sold.

BlackRock Institutional Trust first reported a position in CBST in Q2 2013 and held it in 7 quarters. The position peaked at $212M in Q4 2014. 0 funds tracked by Wall St. Rank hold CBST as of Q1 2015.

  • BlackRock Institutional Trust reported no remaining CUBIST PHARMACEUTICALS INC position as of Q1 2015 after selling out during the quarter.
  • BlackRock Institutional Trust sold 2,103,858 CUBIST PHARMACEUTICALS INC shares in Q1 2015, an estimated $212M.
  • BlackRock Institutional Trust first reported a position in CUBIST PHARMACEUTICALS INC in Q2 2013 and held it in 7 quarters.
  • BlackRock Institutional Trust's CUBIST PHARMACEUTICALS INC position peaked at $212M in Q4 2014.
  • 0 funds tracked by Wall St. Rank held CUBIST PHARMACEUTICALS INC as of Q1 2015.

Based on BlackRock Institutional Trust's 13F filing for Q1 2015, filed 13 May 2015.